For all the hype around AI in drug discovery (some of it justified, much not), the fact that the clinical side of R&D consumes roughly two thirds of total spend tends to go under the radar. Thus the need for operational improvements in the clinical trial process is very clear cut. Ideally, faster recruitment, improved patient segmentation and the like will result in both more rapid trails and a concomitant increase in POS
For all the hype around AI in drug discovery (some of it justified, much not), the fact that the clinical side of R&D consumes roughly two thirds of total spend tends to go under the radar. Thus the need for operational improvements in the clinical trial process is very clear cut. Ideally, faster recruitment, improved patient segmentation and the like will result in both more rapid trails and a concomitant increase in POS